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■ RESEARCH LETTER ■
Pelvic fibromatosis, also known as desmoid tumor, is
a benign neoplasm with no metastatic potential [1]. 
It accounts for about 0.03% of all neoplasms [2]. Patho-
physiologically, it is a deep, infiltrative fibroproliferative
process involving the fascia and muscle aponeurosis.
The mean age at the time of diagnosis is 41.3 years
[3]. The most common sites are the anterior abdominal
wall and shoulder girdle. Spread of aggressive fibro-
matosis can cause compression of the intestine, bladder,
ureter, vagina, and pelvic nerves and vessels, leading to
its symptomatology, morbidity and mortality. It is highly
associated with female sex [3], surgery or trauma (4-fold
risk), pregnancy, familial polyposis coli (10–15% of 
the cases) [4,5] and Gardner’s syndrome. The reported
recurrence rate after surgery is 45% [6].
A 40-year-old woman weighing 79 kg presented
with a 2-month history of abdominal distension. The
distension was sudden in onset and painless, but had
been associated with indigestion and epigastric pain
and urinary symptoms including frequency, urgency, and
dull aching pain in the left lumbar region for 1 week.
She was the mother of four children, the youngest of
whom had been delivered by lower segment cesarean
section 3 years before. Her menstrual cycles and bowel
habits were normal, and there were no neurologic
symptoms. Examination revealed a huge (38 × 36 cm)
immobile, non-tender and solid mass, extending from
the suprapubic area to the xiphisternum. There was no
fluid thrill or shifting dullness. Speculum examination
revealed a healthy-looking cervix and a hard, immobile
mass filling all the fornices on bimanual palpation.
The uterus was not felt separately. All routine blood
investigations and tumor markers were within normal
limits. Abdominopelvic ultrasonography revealed a large
mass of mixed echogenicity that was mainly solid, with
a few cystic lesions arising from the pelvis and extend-
ing to the epigastrium. The uterus and ovaries could
not be visualized because of the large mass that was
clearly separate from the liver, gall bladder, pancreas,
and spleen. The kidneys, ureters, and bladder were all
normal. Computed tomography (CT) examination of
the abdomen and pelvis confirmed a soft-tissue density
mass of 26 × 13 × 24 cm completely filling the pelvis,
and extending into the abdomen with mild to moderate
hydroureter and hydronephrosis (Figures 1 and 2). There
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Figure 1. Computed tomography scan shows tumor (trans-
verse view).
Figure 2. Computed tomography scan shows tumor (sagittal
view).
was no evidence of pelvic lymphadenopathy or ascites.
All visible soft tissues were normal. The uterus and
ovaries were not visualized separately from the mass. 
A provisional diagnosis of an ovarian mass was made.
The patient and relatives received counseling with a
view to performing exploratory laparotomy. Gut prepa-
ration and urologic consultation were performed fol-
lowed by bilateral DJ stenting, prior to the procedure.
Operative findings showed no ascites, but a huge, solid
lobulated mass was detected attached to the anterior
abdominal wall, omentum, and bladder, apparently
arising from the fibrous tissue at the posterior surface
of the pubic bone. The liver and under-surface of the
diaphragm were free. The para-aortic lymph nodes
were not enlarged and the uterus, Fallopian tubes, and
ovaries were healthy and separate from the mass. A
multidisciplinary team including a general surgeon and
a urologist were involved in the complete resection of
the mass, followed by repair of the bladder, which was
opened during the procedure. The patient was trans-
ferred to the intensive care unit in view of the massive
surgery, but she remained stable. Drains were removed
on the third postoperative day and the DJ stent and ure-
thral catheter were removed on the fifth postoperative
day. The patient was discharged on the seventh post-
operative day, in a healthy condition. The tumor weighed
6.5kg. Histopathologic examination confirmed the mass
as intra-abdominal pelvic fibromatosis (Figure 3). The
patient remained well with excellent wound healing at
her 6-month follow-up. A repeat evaluation was planned
after a further 6 months, in light of the high recurrence
rate for this type of tumor.
Pelvic desmoid tumors are rare neoplasms with
only 31 previously reported cases [7]. Intra-abdominal
tumors remain asymptomatic until their growth and in-
filtration leads to intestinal, vascular, ureteric, and neu-
ronal manifestations. Their etiology is uncertain, but may
be related to trauma or hormonal factors, or may have
some genetic associations (familial polyposis gene on
chromosome 5). They commonly occur in young women
during or after pregnancy, and are reported to regress
after menopause [8]. Estrogen receptors have therefore
been implicated in the pathogenesis of the disease.
The most common differential diagnoses include
fibrosarcoma and Gardner’s syndrome. The diagnos-
tic workup involves immunostaining with vimentin, 
α-smooth muscle actin, muscle actin, and desmin.
Mutational analysis of the gene for adenomatous poly-
posis coli is also recommended because of the high
association between these diseases. Magnetic reso-
nance imaging is considered to be superior to CT in
determining the extent of the tumor and its relation-
ship to nearby structures, and during follow-up to detect
any recurrence after surgery. The final diagnosis is based
on histopathologic examination.
Tumors are usually 3–7 cm in size [9], though the
current patient presented with a short history of ab-
dominal distention and a huge mass filling the whole
abdomen. A CT scan showed a bilobed mass filling the
whole abdomen and pelvis, but the exact site of origin
remained unclear. Tumor markers are of no diagnostic
use as previous reports have always found them to be
negative, as in this case [10,11]. Wide surgical excision
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Figure 3. Myofibroblast proliferation with dense collagenous
background. (Haematoxylin & eosin stain. Original magnifi-
cation, x40)
Table. Outcome of various treatment modalities
Study Type of study Treatment options Outcome
Huang et al [6] Case report Surgical removal Recurrence after 2 yr
Sportiello & Case report Surgery, surgery + radiotherapy, Recurrence, recurrence, no 
Hoogerland [12] tamoxifen recurrence after 27 mo
Nuyttens et al [5] Comparative Surgery, surgery + radiotherapy, Cases treated with surgery +
review radiotherapy radiotherapy or radiotherapy
alone had best outcome
Mariana et al [11] Case series Surgery alone Recurrence in 3/6 cases
Bhama et al [14] Case report Surgery + doxorubicin & ifosfamide Complete resolution
was performed and the entire mass was removed suc-
cessfully, in accordance with the standard management
for primary tumors [12].
This type of tumor is associated with very high recur-
rence rate, even after complete surgical removal, and
tamoxifen and other antiestrogens have been reported
to be successful in such cases [11,13,14]. Although
radiotherapy and chemotherapy using dacarbazine,
carboplatin and doxorubicin can also be associated
with good results [15–17], they are associated with their
own side effects and are usually reserved for recurrent
aggressive tumors requiring multiple surgeries. Tamoxifen
should therefore be the first choice of treatment in
recurrent cases, in view of its reduced side effects com-
pared to chemotherapeutic agents. However, further
clinical trials are needed to decide the optimal manage-
ment strategy for these tumors because of their high
recurrence rate.
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